Your browser doesn't support javascript.
loading
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Badar, Talha; Hari, Parameswaran; Dávila, Omar; Fraser, Raphael; Wirk, Baldeep; Dhakal, Binod; Freytes, Cesar O; Rodriguez Valdes, Cesar; Lee, Cindy; Vesole, David H; Malek, Ehsan; Hildebrandt, Gerhard C; Landau, Heather; Murthy, Hemant S; Lazarus, Hillard M; Berdeja, Jesus G; Meehan, Kenneth R; Solh, Melhem; Diaz, Miguel Angel; Kharfan-Dabaja, Mohamed A; Callander, Natalie S; Farhadfar, Nosha; Bashir, Qaiser; Kamble, Rammurti T; Vij, Ravi; Munker, Reinhold; Kyle, Robert A; Chhabra, Saurabh; Hashmi, Shahrukh; Ganguly, Siddhartha; Jagannath, Sundar; Nishihori, Taiga; Nieto, Yago; Kumar, Shaji; Shah, Nina; D'Souza, Anita.
Afiliação
  • Badar T; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hari P; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dávila O; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Fraser R; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Wirk B; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Dhakal B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
  • Freytes CO; Blood and Marrow Transplantation and Cellular Therapy, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Rodriguez Valdes C; Texas Transplant Institute, San Antonio, Texas.
  • Lee C; Wake Forest Baptist Health, Winston-Salem, North Carolina.
  • Vesole DH; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Malek E; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.
  • Hildebrandt GC; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Landau H; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Murthy HS; Bone Marrow Transplant Service, Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lazarus HM; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, Florida.
  • Berdeja JG; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Meehan KR; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Solh M; Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
  • Diaz MA; Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Kharfan-Dabaja MA; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Callander NS; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Mayo Clinic Florida, Jacksonville, Florida.
  • Farhadfar N; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Bashir Q; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
  • Kamble RT; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vij R; Center for Cell and Gene Therapy, Division of Hematology and Oncology, Baylor College of Medicine, Houston, Texas.
  • Munker R; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Kyle RA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Chhabra S; Mayo Clinic Rochester, Rochester, Minnesota.
  • Hashmi S; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ganguly S; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Jagannath S; Department of Internal Medicine, Mayo Clinic, Rochester, New York.
  • Nishihori T; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Nieto Y; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Kumar S; Mount Sinai Medical Center, New York, New York.
  • Shah N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • D'Souza A; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 127(1): 82-92, 2021 01 01.
Article em En | MEDLINE | ID: mdl-32966625
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Translocação Genética / Transplante Autólogo / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Translocação Genética / Transplante Autólogo / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article